Calcitonin gene-related peptide: Vasoactive effects and potential therapeutic role

General Pharmacology

Volumn 27, Issue 4, 1996, Pages 607-611

  Brain, Susan D ^a   Cambridge, Heather ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Calcitonin gene related peptide; Cardiovascular; CGRP; Microvascular; Vascular

Indexed keywords

ADRENOMEDULLIN; AMYLIN; CALCITONIN GENE RELATED PEPTIDE;

DRUG EFFECT; DRUG SYNTHESIS; HORMONE ACTION; HORMONE METABOLISM; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASODILATATION;

EID: 0030176203     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)00125-5     Document Type: Review

References (35)

1. Amara S. G., Jones V., Rosenfeld M. G., Ong E. S. and Evans R. M. (1982) Alternative RNA processing in calcitonin gene expression generates mRNA encoding different polypeptide products. Nature 298, 240-244.
2. Brain S. D., Tippins J. R., Morris H. R., MacIntyre I. and Williams T. J. (1986) Potent vasodilator activity of calcitonin gene-related peptide in human skin. J. Invest. Dermatol. 87, 533-556.
3. Brain S. D. and Williams T. J. (1985) Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br. J. Pharmac. 86, 855-860.
4. Brain S. D. and Williams T. J. (1988) Substance P regulates the vasodilator activity of calcitonin gene-related peptide. Nature 335, 73-75.
5. Brain S. D., Williams T. J., Tippins J. R., Morris H. R. and MacIntyre I. (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature 313, 54-56.
6. Buckley T. L., Brain S. D., Collins P. D. and Williams T. J. (1991) Inflammatory edema induced by interactions between IL-1 and the neuropeptide calcitonin gene-related peptide. J. Immunol. 146, 3424-3430.
7. Chiba T., Yamaguchi A., Yamatani T., Nakamura A., Morishita T., Inui T., Fukase M., Noda T. and Fujita T. (1989) Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am. J. Physiol. 256, E331-E335.
8. Cooper G. J. S. (1994) Amylin compared with calcitonin gene-related peptide: Structure, biology, and relevance to metabolic disease. Endocr. Rev. 15, 163-201.
9. 8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J. Pharmac. exp. Ther. 254, 123-128.
10. Dennis T., Fournier A., St. Pierre S. and Quirion R. (1989) Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J. Pharmac. exp. Ther. 251, 718-725.
11. Edvisson L. (1991) Innervation and effects of dilatory neuropeptides on cerebral vessels. New aspects. Blood Vessels 28, 35-45.
12. 8-37) on skin vasodilatation and oedema induced by stimulation of the rat saphenous nerve. Br. J. Pharmac. 110, 772-776.
13. Gardiner S. M., Compton A. M., Kemp P. A., Bennett T., Bose C., Foulkes R. and Hughes B. (1990) Antagonistic effect of human αCGRP[8-37] on the in vivo regional haemodynamic actions of humans α-CGRP. Biochem. biophys. Res. Commun. 171, 938-943.
14. Goodman, E. C. and Iversen L. L. (1986) Calcitonin gene-related peptide: Novel neuropeptide. Life Sci. 38, 2169-2178.
15. Gray D. W. and Marshall I. (1992) Nitric oxide synthesis inhibitors attenuate calcitonin gene-related peptide endothelium-dependent vasorelaxation in rat aorta. Eur. J. Pharmac. 212, 37-42.
16. Holzer P. (1988) Local effector functions of capsaicin-sensitive sensory nerve endings: Involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 24, 739-768.
17. Holzer P. (1992) Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds. Rev. Physiol. Biochem. Pharmac. 121, 49-146.
18. Jansco N., Jansco-Gabor A. and Szolcsanyi J. (1967) Direct evidence for neurogenic inflammation and its prevention by denervation and pretreatment with capsaicin. Br. J. Pharmac. 31, 138-151.
19. Katayama M., Nadel J. A., Bunnett N. W., Di Maria G. U., Haxhiu M. and Borson D. B. (1991) Catabolism of calcitonin gene-related peptide and substance P by neutral endopeptidase. Peptides 12, 563-567.
20. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H. and Eto T. (1993) Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192, 553-560.
21. Maggi C. A. (1991) The pharmacology of the efferent function of sensory nerves. J. Auton. Pharmac. 11, 173-208.
22. Moskowitz M. A. (1993) Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 43, S16-S20.
23. Mulderry P. K., Ghatei M. A., Spokes R. A., Jones P. M., Pierson A. M., Hamid Q. A., Kanse S., Armara S. G., Burrin J. M., Legon S., Polak J. M. and Bloom S. R. (1988) Differential expression of α-CGRP and β-CGRP by primary sensory neurones and enteric autonomic neurons of the rat. Neuroscience 25, 195-205.
24. + channels. Nature 344, 770-773.
25. Poyner D. G. (1992) Calcitonin gene-related peptide: Multiple actions, multiple receptors. Pharmac. Ther. 56, 23-51.
26. Preibisz J. J. (1993) Calcitonin gene-related peptide and regulation of human cardiovascular homeostasis. Am. J. Hypertens. 6, 434-450.
27. Rink T. J., Beaumont K., Koda J. and Young A. (1993) Structure and biology of amylin. Trends Pharmac. Sci. 14, 113-118.
28. Rosenfeld M. G., Marmod J-J., Amara S. G., Swanson L. W., Sawchenko P. E., Rivier J., Vale W. W. and Evans R. M. (1983) Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304, 129-135.
29. Sexton P. M. (1991) Central nervous system binding sites for calcitonin and calcitonin gene-related peptide. Mol. Neurobiol. 5, 251-273.
30. Shawket S. A. and Brown M. W. (1991) Pathogenetic and therapeutic implications of the calcitonin gene-related peptide in the cardiovascular system. Trends Cardiovasc. Med. 1, 211-215.
31. Shekhar Y. C., Anand I. S., Sarma R., Ferrar R., Wahi P. L. and Poole-Wilson P. A. (1991) Effects of prolonged infusion of human alpha calcitonin gene-related peptide on hemodynamics, renal blood flow and hormone levels in congestive heart failure. Am. J. Cordiol. 67, 732-736.
32. Shulkes A. (1993) Calcitonin gene-related peptide. Potential role in vascular disorders. Drugs and Aging 3, 189-194.
33. Struthers A. D., Brown M. J., MacDonald E. W., Morris H. R., MacIntyre I., Beacham J. L. and Stevenson J. D. (1985) Human calcitonin gene-related peptide: a potent endogenous vasodilator in man. Clin. Sci. 70, 389-393.
34. Tache Y., Holzer P. and Rosenfeld M. G. (Editors) (1992) Calcitonin gene-related peptide. Ann N.Y. Acad. Sci. 657.
35. Uren A. G., Seydoux C. and Davies G. J. (1992) Effect of intravenous calcitonin gene-related peptide on ischaemia threshold and coronary stenosis severity in humans. Cardiovasc. Res. 27, 1477-1481.